ENTITY
Bristol-Myers Squibb

Bristol-Myers Squibb (BMY UN)

2
Analysis
Health CareUnited States
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol Myers Squibb focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
more
bullishAllergan Plc
31 Aug 2019 08:47

Allergan Plc Acquisition by AbbVie Inc. – A Botox Deal with Some Wrinkles

On June 25, 2019, Abbvie Inc (ABBV US) announced its acquisition of Botox-maker Allergan Plc (AGN US) in a $63 billion cash and stock deal in which...

Logo
645 Views
Share
12 Jun 2019 10:05

Immuno-Oncology Drugs in Adjuvant Lung: The Next Frontier in Strengthening Moats

The potential for Merck and Roche looks underappreciated.Innovation in immuno-oncology drugs has supported the moats for Merck & Co Inc. (MRK...

Logo
562 Views
Share
10 Mar 2019 09:17

Last Week in Event SPACE: MYOB, Lynas, Versum, Jardines

Last Week in Event SPACE ... Not a bad reward/risk as Manikay greenmails KKR's MYOB Group Ltd (MYO AU) offer. If the Malaysian government impasse...

Logo
287 Views
Share
07 Mar 2019 12:30Syndicated

Bristol Myers Squib & Celgene–Starboard Objections Addressed Today- Successful Deal Closure Probable

The proposed Bristol Myers Squibb Co (BMY US) & Celgene Corp (CELG US) transaction announced in the first week of 2019, garnered many sceptical...

Logo
213 Views
Share
27 Jan 2019 09:18

Last Week in Event SPACE: Renault/Nissan, Bank Danamon, Kabu, Celgene, Intouch

Last Week in Event SPACE ... The eventual unwind of tension may involve an increase in Nissan Motor (7201 JP)'s stake in Renault SA (RNO FP) and a...

Logo
925 Views
Share
x